Age-Dependent Myeloid Dendritic Cell Responses Mediate Resistance to La Crosse Virus-Induced Neurological Disease

Attenuation of Respiratory Syncytial Virus-Induced and RIG-I-Dependent Type I IFN Responses in Human Neonates and Very Young Children

(2014) N. Marr et al.   JOURNAL OF IMMUNOLOGY

Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death

(2013) Piyali Mukherjee et al.   IMMUNITY

Antiviral Type I and Type III Interferon Responses in the Central Nervous System

(2013) Frédéric Sorgeloos et al.   Viruses-Basel

IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling

(2013) Helen M. Lazear et al.   PLoS Pathogens

Interferon Response Factors 3 and 7 Protect against Chikungunya Virus Hemorrhagic Fever and Shock

(2012) Penny A. Rudd et al.   JOURNAL OF VIROLOGY

Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3–IRF3 signaling and type I interferons in dendritic cells

(2012) Ce Wang et al.   VACCINE

TLR7 and TLR9 Trigger Distinct Neuroinflammatory Responses in the CNS

(2011) Niranjan B. Butchi et al.   AMERICAN JOURNAL OF PATHOLOGY

The spatial epidemiology and clinical features of reported cases of La Crosse Virus infection in West Virginia from 2003 to 2007

(2011) Andrew D Haddow et al.   BMC INFECTIOUS DISEASES

RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity

(2011) Hilario J Ramos et al.   Current Opinion in Virology

Interferon Antagonist NSs of La Crosse Virus Triggers a DNA Damage Response-like Degradation of Transcribing RNA Polymerase II

(2010) Paul Verbruggen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of Human Blood Mononuclear Cells

(2010) Nathan P. Corbett et al.   PLoS One

Phenotype and function of neonatal DC

(2009) Fabienne Willems et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Measure and Countermeasure: Type I IFN (IFN-α/β) Antiviral Response against West Nile Virus

(2009) Stephane Daffis et al.   Journal of Innate Immunity

The Incidence Risk, Clustering, and Clinical Presentation of La Crosse Virus Infections in the Eastern United States, 2003–2007

(2009) Andrew D. Haddow et al.   PLoS One

Assessing Risk in Focal Arboviral Infections: Are We Missing the Big or Little Picture?

(2009) Andrew D. Haddow et al.   PLoS One

Induction of IFN-β and the Innate Antiviral Response in Myeloid Cells Occurs through an IPS-1-Dependent Signal That Does Not Require IRF-3 and IRF-7

(2009) Stephane Daffis et al.   PLoS Pathogens

La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys

(2008) Richard S Bennett et al.   Virology Journal